TetraMax LA 300 INJECTION

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

OXYTETRACYCLINE AS THE DIHYDRATE

Available from:

ABBEY LABORATORIES PTY LTD

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

OXYTETRACYCLINE AS THE DIHYDRATE ANTIBIOTIC Active 300.0 mg/ml

Units in package:

100mL, 250mL, 500mL

Class:

VM - Veterinary Medicine

Therapeutic area:

ANTIBIOTIC & RELATED

Product summary:

Poison schedule: 4; Withholding period: MEAT (Cattle): DO NOT USE less than 35 d ays before slaughter for human consumpti on. MEAT (Sheep and pigs): DO NOT USE l ess than 28 days before slaughter for hu man consumption. MILK: milk collected f rom cows within 7 days (14 milkings) or ewes within 8 days (16 milkings) followi ng treatment MUST NOT BE USED for human consumption or processing or fed to bobb y calves. Any variation by the prescrib ing veterinarian to the approved dose, f requency, duration, route, disease or ta rget species may result in the need to e xtend the approved withholding period C attle: DO NOT USE less than 35 days befo re slaughter for export. Sheep and Pigs : DO NOT USE less than 28 days before sl aughter for export. Before using this p roduct, confirm the current ESI with Abb ey Animal Health Pty Ltd on 02 8088 0720 or the APVMA website www. apvma.gov.au/ residues/.; Host/pest details: CATTLE: [ACTINOMYCES PYOGENES, ANTIBIOTICS - ORAL, PARENTERAL, ATROPHIC RHINITIS, BACTERIAL INFECTION, BORDETELLA BRONCHISEPTICA, CHLAMYDIA SPP., ERYSIPELAS INFECTION, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, MASTITIS, MYCOPLASMA SPP., ORGANISMS SENSITIVE TO OXYTETRACYCLINE, PASTEURELLA SPP., PNEUMONIA, PROTOZOA, RICKETTSIAE, STAPHYLOCOCCUS SPP., STREPTOCOCCI]; PIGS: [ACTINOMYCES PYOGENES, ANTIBIOTICS - ORAL, PARENTERAL, BACTERIAL INFECTION, BORDETELLA BRONCHISEPTICA, CHLAMYDIA SPP., ERYSIPELAS INFECTION, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, MYCOPLASMA SPP., ORGANISMS SENSITIVE TO OXYTETRACYCLINE, PASTEURELLA SPP., PROTOZOA, RICKETTSIAE, STAPHYLOCOCCUS SPP., STREPTOCOCCI]; SHEEP: [ACTINOMYCES PYOGENES, ANTIBIOTICS - ORAL, PARENTERAL, BACTERIAL INFECTION, BACTERIAL KERATO CONJUNCTIVITIS, BORDETELLA BRONCHISEPTICA, CHLAMYDIA SPP., ENZOOTIC ABORTION, ERYSIPELAS INFECTION, FOOTROT - DICHELOBACTER NODOSUS, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, MYCOPLASMA SPP., ORGANISMS SENSITIVE TO OXYTETRACYCLINE, PASTEURELLA SPP., PROTOZOA, RICKETTSIAE, STAPHYLOCOCCUS SPP., STREPTOCOCCI]

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

TetraMax LA 300 INJECTION
88917/122894
Product Name:
APVMA Approval No:
Label Name:
TetraMax LA 300 INJECTION
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
300 mg/mL OXYTETRACYCLINE (AS THE DIHYDRATE)
Claims:
Broad spectrum antibiotic injection for use in cattle, sheep and pigs.
TetraMax LA 300 is a broad-spectrum antibiotic for use in the
treatment of conditions
caused by, or associated with, organisms sensitive to oxytetracycline
in cattle, sheep and
pigs.
A wide range of gram-positive and gram-negative bacteria, including
Bordetella
bronchiseptica, Actinomyces pyogenes, Erysipelothrix rhusiopathiae,
Pasteurella spp.,
Staphylococcus spp. And Streptococcus spp. Are sensitive to
Oxytetracycline. Certain
Mycoplasma, Rickettsiae, Protozoa and Chlamydia are sensitive to
Oxytetracycline.
This product may be used in the treatment and control of wide range of
common systemic,
respiratory, urinary and local infections caused by Oxytetracycline
organisms. Specific
indications for this product would therefore include: Pasteurellosis,
Pneumonia, Atrophic
rhinitis, erysipelas, joint-ill/navel ill, summer mastitis in cows,
ovine keratoconjuctivitis (pink-
eye), foot rot and enzootic abortion in sheep.
Resistance may develop to any chemical.
Net Contents:
100mL, 250mL, 500mL
Directions for Use:
Restraints:
Contraindications: RLP APPROVED
Precautions:
Side Effects:
Dosage and
Administration:
DO NOT DILUTE.
Use contents within 28 days of first broaching of the vial. Discard
the unused portion.
This product does not contain any antimicrobial preservative. Swab the
septum before
removing each dose. Use a sterile needle and syringe.
If stored as directed, this product can be expected to retain its
potency until the date of
expiry shown on the vial. When the vial has been broached and the
contents exposed to
air, the solution may darken but the potency will be unchanged.
Injections are to be given by deep intramuscular injection into the
neck region for t